Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$1.7B
Enterprise value$1.3B
Revenue$673.0M +20.2%
True FCF (ex-SBC)$-625.0M −12.1%
Rule of 40-49.9%
Operating margin-79.5%
True FCF Yield-35.8%
EPS, diluted$-5.83 +7.3%
Modern Valuation (EOD)
Market Cap$1.7B
Enterprise Value$1.3B
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT—
EV / Sales1.97
P / E (GAAP)—
P / FCF—
P / Oper. CF—
P / Book—
Owner & Cash Yields
True FCF Yield-35.8%
FCF Yield-27.0%
Owner Earn. Yield-40.0%
Earnings Yield-32.9%
Shareholder Yield—
Buyback Yield—
Dividend Yield—
Dividend / sh$0.00
Payout Ratio—
FCF / sh$-4.63
EPS (diluted)$-5.83
Compounder & Returns
Rule of 40-49.9%
ROIC—
Cash ROIC (CROIC)—
GP / Assets—
ROE718.8%
ROA-37.5%
Gross Margin—
Oper. Margin-79.5%
Net Margin-85.4%
FCF Margin-70.1%
True FCF Margin-92.9%
Quality & Dilution
Cash Conversion—
Accrual Ratio−7.1%
SBC % of FCF—
SBC % of Rev22.7%
Reinvest. Rate—
Sales Growth Y/Y+20.2%
Sales 3Y CAGR+22.8%
EPS Growth Y/Y+7.3%
FCF Growth Y/Y−12.1%
FCF 3Y CAGR—
Share Change Y/Y+9.0%
Balance Sheet & Scale
Revenue (FY)$673.0M
Gross Profit (FY)—
Oper. Income (FY)$-535.0M
GAAP Net Income$-575.0M
True FCF (ex-SBC)$-625.0M
Cash & Equiv$421.0M
Total Debt—
Net Cash (Debt)$421.0M
Net Cash % MCap+24.1%
Debt / FCF (yrs)—
Current Ratio2.48101.92M sh
Price & Technicals (EOD)
Perf Week+2.49%
Perf Month+3.32%
Perf Quarter−35.93%
Perf Half Y−29.54%
Perf YTD−34.11%
SMA 20 Dist−0.01%$16.48
SMA 50 Dist+6.27%$15.51
SMA 100 Dist−21.21%$20.92
Window High−54.06%$35.87
Window Low+27.95%$12.88
RSI (14) · Vol50.664%v
Income Distribution & Cash Flow ConversionHow every dollar of RARE revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Standard Free Cash Flow (FCF)$-472.0M(-70.1% margin)
Less: Stock-Based Comp (SBC)−$153.0M
True FCF (Owner Cash ex-SBC)$-625.0M(-92.9% of rev)
Revenue by fiscal year
$351.4MFY21
$363.3MFY22
$434.0MFY23
$560.0MFY24
$673.0MFY25
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$351.4M
$363.3M
$434.0M
$560.0M
$673.0M
+20.2%
+17.6%
Cost of Revenue (COGS)
—
—
—
—
$1.1M
—
—
Research & Development (R&D)
$497.2M
$705.8M
$648.0M
$698.0M
$750.0M
+7.4%
+10.8%
Selling, General & Admin (SG&A)
$220.0M
$278.1M
$310.0M
$321.0M
$349.0M
+8.7%
+12.2%
Operating Income (EBIT) ▸
$-381.7M
$-648.9M
$-569.0M
$-536.0M
$-535.0M
+0.2%
—
Income Tax Expense
$1.0M
$5.7M
$-2.0M
$2.0M
$4.0M
+100.0%
+39.9%
GAAP Net Income ▸
$-454.0M
$-707.4M
$-607.0M
$-569.0M
$-575.0M
−1.1%
—
Diluted EPS ▸
$-6.70
$-10.12
$-8.25
$-6.29
$-5.83
+7.3%
—
Diluted Shares
67.8M
69.9M
73.5M
90.5M
98.6M
+9.0%
+9.8%
Balance Sheet
Cash & Equivalents
$307.6M
$132.9M
$214.0M
$174.0M
$421.0M
+142.0%
+8.2%
Inventory
$16.2M
$26.8M
$34.0M
$45.0M
$52.0M
+15.6%
+33.8%
Total Current Assets
$856.6M
$883.9M
$732.2M
$817.0M
$951.0M
+16.4%
+2.6%
Total Assets
$1.5B
$1.5B
$1.5B
$1.5B
$1.5B
+1.9%
+0.2%
Total Current Liabilities
$181.4M
$261.2M
$280.4M
$344.0M
$384.0M
+11.6%
+20.6%
Total Liabilities
$599.8M
$1.2B
$1.2B
$1.2B
$1.6B
+29.3%
+27.9%
Stockholders' Equity
$922.6M
$352.0M
$275.0M
$255.0M
$-80.0M
−131.4%
—
Net Cash / (Net Debt)
$307.6M
$132.9M
$214.0M
$174.0M
$421.0M
+142.0%
+8.2%
Invested Capital
$615.0M
$219.1M
$61.0M
$81.0M
$-501.0M
−718.5%
—
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-338.7M
$-380.5M
$-475.0M
$-414.0M
$-466.0M
−12.6%
—
Depreciation & Amortization (D&A)
$13.2M
$18.2M
$26.0M
$36.0M
$35.0M
−2.8%
+27.5%
Stock-Based Compensation (SBC)
$105.0M
$130.4M
$135.0M
$158.0M
$153.0M
−3.2%
+9.9%
Capital Expenditures (CapEx)
$73.1M
$116.1M
$44.0M
$7.0M
$6.0M
−14.3%
−46.5%
Free Cash Flow (FCF) ▸
$-411.8M
$-496.6M
$-519.0M
$-421.0M
$-472.0M
−12.1%
—
True FCF (ex-SBC Owner Cash)
$-516.8M
$-627.0M
$-654.0M
$-579.0M
$-625.0M
−7.9%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
20 big days in a year, and what we hold on each
A big day is a close more than 6.38% from the one before, three times RARE’s median day (2.13%). On 0 of the 20, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±6.38%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayRAREWhat we hold that dayGroup (median of 4) · each
1 Nov 21, 2025+7.73%
Before our storiesgroup +2.3%, did not move with it
1Nov 21, 2025+7.73%
Before our stories
+2.3% did not move with itABBV +3.0 · MRK +2.9 · LLY +1.6 · JNJ +0.4
2 Dec 3, 2025+8.90%
Before our storiesgroup +0.6%, did not move with it
2Dec 3, 2025+8.90%
Before our stories
+0.6% did not move with itABBV +2.6 · MRK +1.2 · JNJ −0.0 · LLY −1.2
3 Dec 29, 2025−42.32%
Before our storiesgroup +0.0%, did not move with it
3Dec 29, 2025−42.32%
Before our stories
+0.0% did not move with itMRK −0.1 · JNJ −0.0 · LLY +0.1 · ABBV +0.4
4 Dec 30, 2025+15.52%
Before our storiesgroup −0.4%, did not move with it
4Dec 30, 2025+15.52%
Before our stories
−0.4% did not move with itLLY +0.1 · JNJ −0.3 · ABBV −0.5 · MRK −0.5
5 Jan 7, 2026+7.36%
Before our storiesgroup +2.7%, did not move with it
5Jan 7, 2026+7.36%
Before our stories
+2.7% did not move with itABBV +4.2 · LLY +4.1 · JNJ +1.3 · MRK −0.3
6 Jan 12, 2026+8.26%
Before our storiesgroup +0.8%, did not move with it
6Jan 12, 2026+8.26%
Before our stories
+0.8% did not move with itJNJ +2.6 · LLY +1.6 · ABBV −0.0 · MRK −1.2
7 Feb 13, 2026−12.68%
Resultsgroup +1.0%, did not move with it
7Feb 13, 2026−12.68%
ResultsFirst close after the Feb 12 results filing
+1.0% did not move with itJNJ −0.5 · LLY +0.2 · ABBV +1.8 · MRK +1.8
8 Feb 19, 2026+6.75%
Before our storiesgroup +0.2%, did not move with it
8Feb 19, 2026+6.75%
Before our stories
+0.2% did not move with itJNJ +0.8 · LLY +0.3 · MRK +0.2 · ABBV −1.9
9 Mar 9, 2026+6.40%
Before our storiesgroup +1.0%, did not move with it
9Mar 9, 2026+6.40%
Before our stories
+1.0% did not move with itLLY +1.8 · MRK +1.1 · JNJ +0.9 · ABBV −1.2
10 Mar 24, 2026−8.73%
Before our storiesgroup +0.0%, did not move with it
10Mar 24, 2026−8.73%
Before our stories
+0.0% did not move with itLLY −0.8 · JNJ −0.1 · ABBV +0.1 · MRK +0.6
11 Mar 25, 2026+7.30%
Before our storiesgroup +1.7%, did not move with it
11Mar 25, 2026+7.30%
Before our stories
+1.7% did not move with itMRK +2.6 · JNJ +2.0 · LLY +1.5 · ABBV +1.0
12 Mar 31, 2026+8.55%
Before our storiesgroup +1.9%, did not move with it
12Mar 31, 2026+8.55%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
13 May 19, 2026−7.19%
Before our storiesgroup +1.8%, did not move with it
13May 19, 2026−7.19%
Before our stories
+1.8% did not move with itJNJ +0.5 · MRK +1.5 · ABBV +2.1 · LLY +3.4
14 Jun 17, 2026+8.29%
Nothing on RAREgroup −0.5%, did not move with it
14Jun 17, 2026+8.29%
Nothing on RARENo RARE story, brief or results filing in our record that day
−0.5% did not move with itMRK +0.2 · JNJ −0.4 · ABBV −0.6 · LLY −0.9
15 Jun 30, 2026+8.83%
Nothing on RAREgroup −1.4%, did not move with it
15Jun 30, 2026+8.83%
Nothing on RARENo RARE story, brief or results filing in our record that day
−1.4% did not move with itMRK −0.7 · ABBV −1.1 · JNJ −1.8 · LLY −2.5
16 Jul 7, 2026+6.44%
Nothing on RAREgroup +2.3%, did not move with it
16Jul 7, 2026+6.44%
Nothing on RARENo RARE story, brief or results filing in our record that day
+2.3% did not move with itJNJ +3.0 · LLY +3.0 · MRK +1.6 · ABBV −0.0
17 Sep 3, 2026−44.03%
Nothing on RAREgroup +0.2%, did not move with it
17Sep 3, 2026−44.03%
Nothing on RARENo RARE story, brief or results filing in our record that day
+0.2% did not move with itABBV −0.6 · LLY −0.0 · MRK +0.5 · JNJ +1.2
18 Sep 17, 2026+12.58%
Nothing on RAREgroup +1.2%, did not move with it
18Sep 17, 2026+12.58%
Nothing on RARENo RARE story, brief or results filing in our record that day
+1.2% did not move with itMRK +1.6 · LLY +1.3 · JNJ +1.1 · ABBV +0.6
19 Sep 22, 2026+6.59%
Nothing on RAREgroup +0.4%, did not move with it
19Sep 22, 2026+6.59%
Nothing on RARENo RARE story, brief or results filing in our record that day
+0.4% did not move with itMRK +0.9 · LLY +0.5 · ABBV +0.3 · JNJ −0.1
20 Nov 5, 2026−9.27%
Nothing on RAREgroup −2.3%, did not move with it
20Nov 5, 2026−9.27%
Nothing on RARENo RARE story, brief or results filing in our record that day
−2.3% did not move with itLLY −3.8 · MRK −2.3 · ABBV −2.2 · JNJ −1.4
A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in RARE’s SEC industry; “moved with RARE” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). RARE reports after the close, so day 1 is the next close. 3 of 4 times, day 6 ended on the same side as day 1.
Reported Feb 12, 2026
day 1−12.68%day 6−4.21%
Reported May 5, 2026
day 1+3.68%day 6+5.80%
Reported Aug 4, 2026
day 1−3.41%day 6+4.07%
Reported Nov 3, 2026
day 1+3.19%day 6+0.42%
Next report: expected early-to-mid FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 3 report: +3.55%. Four reports is a small sample.
Each line is RARE’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
RARE against four drug peers, a year at 100
RARE is down 48.7% in a year. Merck is up 35.8%, Johnson & Johnson 31.0%, Eli Lilly 27.5% and AbbVie 20.0%. All four did more. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in RARE’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.